Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

51.06
Delayed Data
As of Jul 29
 +0.12 / +0.24%
Today’s Change
39.28
Today|||52-Week Range
51.74
+13.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues38.9B39.9B21.8B20.2B
 
 
 
 
 
Cost of Goods Sold12.4B12.4B9.1B8.2B
 
 
 
 
 
Depreciation And Amortization3.0B2.8B1.7B1.5B
 
 
 
 
 
 
Operating ExpensesGross Income23.4B24.7B11.0B10.5B
 
 
 
 
 
General Expenses16.7B16.1B8.3B4.3B
 
 
 
 
 
Research And Development4.0B4.2B1.5B1.3B
 
 
 
 
 
Total Operating Expenses32.1B31.3B19.2B14.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.7B8.6B2.7B6.2B
 
 
 
 
 
Extraordinary Credit477.0M170.0M0.00--
 
 
 
Extraordinary Charge-1.0B-2.0B-82.0M-3.6B
 
 
 
 
 
Interest Expense On Debt1.0B673.4M76.0M177.0M
 
 
 
 
 
Other Expenses-41.4M72.3M-69.0M35.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.2B6.3B2.5B2.5B
 
 
 
 
 
Income Taxes-470.2M-299.7M-138.0M-797.0M
 
 
 
 
 
Discontinued Operations0.000.00193.0M563.0M
 
 
 
Net Income4.7B6.0B2.6B2.3B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6B1.6B1.6B1.5B
 
 
 
 
 
Shares To Calculate EPS Diluted1.6B1.6B1.6B1.5B
 
 
 
 
 
 
Earnings Per ShareEPS$3.01$3.72$1.62$1.49
 
 
 
 
 
EPS Diluted$3.01$3.72$1.64$1.50